mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.01 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |